Nusano News
Quantum and Nusano Collaborate to Advance North American Critical Mineral Refining
The following is a copy of a press release issued by Quantum Critical Metals. Click here to view the original press release on TheNewswire.VANCOUVER, B.C., Canada and...
Nusano Receives Innovation Impact Award from BioUtah
Company’s radioisotope production platform recognized for potential impact on next-generation cancer diagnostics and therapeuticsSALT LAKE CITY – Nov. 12, 2025 – Nusano, a physics company enabling industries ranging from healthcare to nuclear energy, today accepted...
Clarity signs copper-67 Supply Agreement with Nusano
The following is a copy of a press release issued by Clarity Pharmaceuticals Sydney, Australia 16 October 2025 Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products...
Nusano and Ariceum Therapeutics Announce Multi-Isotope Supply Agreement
Agreement includes Actinium-225 (Ac-225) and Lutetium-177 (Lu-177) to support Ariceum’s therapeutic programsWEST VALLEY CITY, Utah and BERLIN, Germany – Oct. 14, 2025 – Nusano, a physics company transforming the production of radioisotopes, and Ariceum Therapeutics...
Nusano Announces September 2025 Conference Schedule
WEST VALLEY CITY, Utah – Sept. 4, 2025 – Nusano, a leader in advanced isotope and energy technologies, today announced its September conference schedule. Nusano CEO Chris Lowe will participate in panel discussions and company leadership will be available for...
Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility
Pictured (L-R): Howard Lewin, Nusano co-founder & Chief Product Development Officer; Glenn Rosenthal, Nusano co-founder & Chief Technology Officer; Chris Lowe, Nusano CEO; John Dahlstrom, EVP, Wasatch Group; and Utah Gov. Spencer Cox. Utah Governor...
Nusano Establishes Strategic Advisory Board to Support Innovation Across Company’s Product Verticals
The Honorable Dr. David J. Shulkin, Corey Johnston and Seema Singh Bhan Appointed as Initial Advisory Board MembersWEST VALLEY CITY, Utah – Aug. 7, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the formation of a...
Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes
Pairing of custom-built klystrons and fast-pulse modulators enable production of up 12 radioisotopes in a single run Power and efficiency of Nusano system to surpass existing commercial methodologies Beam time reservations and isotope supply agreements underway WEST...
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
The following is a copy of a press release issued by Cellectar BiosciencesPartnership Provides Long-Term Supply of Iodine-125 and Actinium-225 Supports Advancement of Radiotherapeutic Pipeline and Plans to Initiate Phase 1b Clinical Trial of CLR-125 for...
dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapies DURHAM, N.C. and WEST VALLEY CITY, Utah – June 19, 2025 – dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a...
Ratio Therapeutics and Nusano Enter Long-Term, Multi-Isotope Supply Agreement to Boost Production of Cancer Radiopharmaceuticals
Agreement provides Ratio access to Nusano-produced radioisotopes for oncology diagnostics and therapeutics Accelerates Ratio’s clinical pipeline with copper-64 for PET imaging and lutetium-177 and actinium-225 for targeted therapy Bolsters both companies’...
BLOG Posts
A Declaration of Critical Minerals Independence
Innovation in Critical Mineral Mining and Processing Must Be a National PriorityCHRIS LOWECEO,...
Chris Lowe on Healthcare Technology Report Podcast
Nov. 6, 2025 – Nusano CEO, Chris Lowe, is the featured guest on the new edition of the Healthcare Technology Report...
BioUtah Recognizes Nusano with Innovation Impact Award
SALT LAKE CITY – Nov. 5, 2025 – Nusano is honored to receive the 2025 Innovation Impact Award from BioUtah. The award...
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates